USPatentGranted
B2

Biaryl ether sulfonamides and their use as therapeutic agents

Granted 14 Jun 2016 · 2 office actions

Life of the patent

21 dated events
⤢ drag to zoom20122014201620182020202220242026202820302032ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

This invention is directed to biaryl ether sulfonamides, or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

Claims

17 · 1 independent · depth 6
1234567891011121314151617
17 granted claims

Classifications

6 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C07D403/12
  • C07D473/00
  • C07D417/14
  • C07D471/04
  • C07D417/12
  • C07D487/04

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016USPTOApplicantNon-final rejectionResponse after non-finalRequest for continued examinationRequest for continued examinationRequest for continued examination
USPTOApplicanthover for detail · click to open
Pendency
3.6 y
1,323 days filing → grant
Office actions
1
non-final + final
Responses
3
6 RCE
Interviews
1
examiner interview summaries
Examiner
Niloofar Rahmani
art unit 1625 · TC 1600
Citations: 223 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

2 priority documents
Priority
31 Oct 2011
earliest claimed
›Priority documents — 2
TypeDocumentDate
provisionalUS 6155373031 Oct 2011
related publicationUS 20140256736 A111 Sep 2014

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock